Literature DB >> 12678659

Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia.

J Neckár1, O Sźárszoi, J Herget, B Ostádal, F Kolár.   

Abstract

The effect of chronic hypercapnia on cardioprotection induced by chronic hypoxia was investigated in adult male Wistar rats exposed to isobaric hypoxia (10 % O(2)) for three weeks. In the first experimental group, CO(2) in the chamber was fully absorbed; in the second group, its level was increased to 4.1 %. Normoxic controls were kept in atmospheric air. Anesthetized open-chest animals were subjected to 20-min LAD coronary artery occlusion and 3-h reperfusion for infarct size determination (TTC staining). Chronic hypoxia alone reduced body weight and increased hematocrit; these effects were significantly attenuated by hypercapnia. The infarct size was reduced from 61.9+/-2.2 % of the area at risk in the normoxic controls to 44.5+/-3.3 % in the hypoxic group (P<0.05). Hypercapnia blunted the infarct size-limiting effect of hypoxia (54.8+/-2.4 %; P<0.05). It is concluded that increased CO(2) levels in the inspired air suppress the development of the chronic hypoxia-induced cardioprotective mechanism, possibly by interacting with ROS signalling pathways.

Entities:  

Mesh:

Year:  2003        PMID: 12678659

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  8 in total

Review 1.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

2.  Cardioprotective Effect of Opioids, Derivatives of Amide N-Methyl-2-(Pirrolidin-1-yl)Cyclohexyl-1-Amine, under Conditions of Ischemia/Reperfusion of the Heart.

Authors:  A V Mukhomedzyanov; V V Zhuk; L N Maslov; A I Shipunov; O S Andrienko; R M Gadirov
Journal:  Bull Exp Biol Med       Date:  2021-04-24       Impact factor: 0.804

3.  Tolerance of the developing cyanotic heart to ischemia-reperfusion injury in the rat.

Authors:  Yasuhiro Fujii; Kozo Ishino; Tomoko Tomii; Hitoshi Kanamitsu; Hideya Mitsui; Shunji Sano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

4.  δ2-Opioid Receptors as a Target in Designing New Cardioprotective Drugs: the Role of Protein Kinase C, AMPK, and Sarcolemmal KATP Channels.

Authors:  A V Mukhomedzyanov; S V Popov; L N Maslov
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

5.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

6.  Comparative Analysis of Infarct Size Limiting Activity of κ-Opioid Receptor Agonists in In Vivo Reperfused Heart.

Authors:  A V Mukhomedzyanov; S Yu Tsibulnikov; L N Maslov
Journal:  Bull Exp Biol Med       Date:  2021-04-01       Impact factor: 0.804

7.  Comparative Analysis of Infarct Size Limiting Activity of δ-Opioid Receptor Agonists in Reperfused Heart In Vivo.

Authors:  A V Mukhomedzyanov; S Yu Tsibulnikov; A V Krylatov; L N Maslov
Journal:  Bull Exp Biol Med       Date:  2021-04-01       Impact factor: 0.804

8.  Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-α Levels in Rats with Pulmonary Artery Hypertension.

Authors:  Jie Shu; Wei Liu; Fei Han; Fanyan Luo
Journal:  Biomed Res Int       Date:  2019-11-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.